Clinical Trial Update: EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis [NA]

View source ↗

Summary

Completed clinical trial studying early interferon beta-1a combined with atorvastatin for isolated clinical syndrome suggestive of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon beta-1a (Interferon beta-1a)
• atorvastatin (atorvastatin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Multiple Sclerosis | NA | Status: COMPLETED